<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="protocol"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="hwp">bmjopen</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24861549</article-id><article-id pub-id-type="pmc">4039866</article-id><article-id pub-id-type="publisher-id">bmjopen-2014-004966</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2014-004966</article-id><article-categories><subj-group subj-group-type="heading"><subject>Intensive Care</subject><subj-group><subject>Protocol</subject></subj-group></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>1707</subject><subject>1707</subject><subject>1727</subject></subj-group></article-categories><title-group><article-title>IMPOSE (IMProving Outcomes after Sepsis)&#x02014;the effect of a multidisciplinary follow-up service on health-related quality of life in patients postsepsis syndromes&#x02014;a double-blinded randomised controlled trial: protocol</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Paratz</surname><given-names>Jennifer D</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref><xref ref-type="aff" rid="af3">3</xref><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kenardy</surname><given-names>Justin</given-names></name><xref ref-type="aff" rid="af5">5</xref></contrib><contrib contrib-type="author"><name><surname>Mitchell</surname><given-names>Geoffrey</given-names></name><xref ref-type="aff" rid="af6">6</xref></contrib><contrib contrib-type="author"><name><surname>Comans</surname><given-names>Tracy</given-names></name><xref ref-type="aff" rid="af7">7</xref></contrib><contrib contrib-type="author"><name><surname>Coyer</surname><given-names>Fiona</given-names></name><xref ref-type="aff" rid="af8">8</xref></contrib><contrib contrib-type="author"><name><surname>Thomas</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Singh</surname><given-names>Sunil</given-names></name><xref ref-type="aff" rid="af9">9</xref></contrib><contrib contrib-type="author"><name><surname>Luparia</surname><given-names>Louise</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Boots</surname><given-names>Robert J</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref></contrib></contrib-group><aff id="af1"><label>1</label><institution>Burn, Trauma and Critical Care Research Centre, The University of Queensland</institution>, <addr-line>Brisbane, Queensland</addr-line>, <country>Australia</country></aff><aff id="af2"><label>2</label><addr-line>Department of Intensive Care Medicine</addr-line>, <institution>Royal Brisbane &#x00026; Women's Hospital</institution>, <addr-line>Brisbane, Queensland</addr-line>, <country>Australia</country></aff><aff id="af3"><label>3</label><institution>School of Rehabilitation Sciences, Griffith University</institution>, <addr-line>Brisbane, Queensland</addr-line>, <country>Australia</country></aff><aff id="af4"><label>4</label><addr-line>Department of Physiotherapy</addr-line>, <institution>Royal Brisbane &#x00026; Women's Hospital</institution>, <addr-line>Brisbane, Queensland</addr-line>, <country>Australia</country></aff><aff id="af5"><label>5</label><institution>CONROD, The University of Queensland</institution>, <addr-line>Brisbane, Queensland</addr-line>, <country>Australia</country></aff><aff id="af6"><label>6</label><institution>School of Medicine (Ipswich Campus), The University of Queensland</institution>, <addr-line>Ipswich</addr-line>, <country>Australia</country></aff><aff id="af7"><label>7</label><institution>School of Medicine, Griffith University</institution>, <addr-line>Brisbane, Queensland</addr-line>, <country>Australia</country></aff><aff id="af8"><label>8</label><addr-line>Nursing Faculty</addr-line>, <institution>Queensland University of Technology</institution>, <addr-line>Brisbane, Queensland</addr-line>, <country>Australia</country></aff><aff id="af9"><label>9</label><addr-line>Intensive Care Unit</addr-line>, <institution>Bundaberg Hospital</institution>, <addr-line>Bundaberg, Queensland</addr-line>, <country>Australia</country></aff><author-notes><corresp><label>Correspondence to</label> Dr Jennifer D Paratz; <email>j.paratz@uq.edu.au</email></corresp></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>24</day><month>5</month><year>2014</year></pub-date><volume>4</volume><issue>5</issue><elocation-id>e004966</elocation-id><history><date date-type="received"><day>31</day><month>1</month><year>2014</year></date><date date-type="rev-recd"><day>29</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>30</day><month>4</month><year>2014</year></date></history><permissions><copyright-statement>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link></license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="bmjopen-2014-004966.pdf"/><self-uri content-type="draft-revisions-pdf" xlink:type="simple" xlink:href="bmjopen-2014-004966.draft_revisions.pdf"/><self-uri content-type="reviewers-comments-pdf" xlink:type="simple" xlink:href="bmjopen-2014-004966.reviewer_comments.pdf"/><abstract><sec><title>Introduction</title><p>Patients post sepsis syndromes have a poor quality of life and a high rate of recurring illness or mortality. Follow-up clinics have been instituted for patients postgeneral intensive care but evidence is sparse, and there has been no clinic specifically for survivors of sepsis. The aim of this trial is to investigate if targeted screening and appropriate intervention to these patients can result in an improved quality of life (Short Form 36 health survey (SF36V.2)), decreased mortality in the first 12&#x02005;months, decreased readmission to hospital and/or decreased use of health resources.</p></sec><sec><title>Methods and analysis</title><p>204 patients postsepsis syndromes will be randomised to one of the two groups. The intervention group will attend an outpatient clinic two monthly for 6&#x02005;months and receive screening and targeted intervention. The usual care group will remain under the care of their physician. To analyse the results, a baseline comparison will be carried out between each group. Generalised estimating equations will compare the SF36 domain scores between groups and across time points. Mortality will be compared between groups using a Cox proportional hazards (time until death) analysis. Time to first readmission will be compared between groups by a survival analysis. Healthcare costs will be compared between groups using a generalised linear model. Economic (health resource) evaluation will be a within-trial incremental cost utility analysis with a societal perspective.</p></sec><sec><title>Ethics and dissemination</title><p>Ethical approval has been granted by the Royal Brisbane and Women&#x02019;s Hospital Human Research Ethics Committee (HREC; HREC/13/QRBW/17), The University of Queensland HREC (2013000543), Griffith University (RHS/08/14/HREC) and the Australian Government Department of Health (26/2013). The results of this study will be submitted to peer-reviewed intensive care journals and presented at national and international intensive care and/or rehabilitation conferences.</p></sec><sec><title>Trial registration number</title><p>Australian and New Zealand Clinical Trials Registry ACTRN12613000528752.</p></sec></abstract><kwd-group><kwd>Rehabilitation Medicine</kwd></kwd-group></article-meta></front><body><boxed-text position="float"><caption><title>Strengths and limitations of this study</title></caption><p>
<list list-type="bullet"><list-item><p>This is the first study to concentrate solely on patients with sepsis syndrome postintensive care discharge.</p></list-item><list-item><p>There is a strong multidisciplinary team to provide a multitude of screening tools and interventions.</p></list-item><list-item><p>Individualised management will be provided to patients.</p></list-item><list-item><p>This is a single-centre study, so lacks external generalisibility.</p></list-item></list></p></boxed-text><sec id="s1"><title>Background</title><p>Greater numbers of patients are surviving in intensive care units (ICUs) but a new syndrome called the &#x02018;post-ICU syndrome&#x02019; has appeared with residual physical, cognitive and psychosocial problems lasting from 5 to 15&#x02005;years.<xref rid="R1" ref-type="bibr">1</xref>
<xref rid="R2" ref-type="bibr">2</xref> The rate of a major illness recurring and/or mortality is also increased in the year after ICU discharge, with mortality ranging from 26% to 63% at 1-year postdischarge in long-stay ICU patients (&#x02265;48&#x02005;h).<xref rid="R3" ref-type="bibr">3</xref> ICU survivors additionally often have a number of problems<xref rid="R1" ref-type="bibr">1&#x02013;4</xref> including debility and fatigue from loss of muscle mass, ongoing nutritional problems, difficulty in dealing with altered appearance and function, chronic pain,<xref rid="R5" ref-type="bibr">5</xref> amnesia and delusional symptoms. All of these factors have a major impact on the health and productivity of survivors and their carers, survivors&#x02019; return to work rates, as well as the impact on availability of ICU and hospital beds, surgical waiting lists, health costs and society.<xref rid="R6" ref-type="bibr">6</xref> There has been a &#x02018;call to arms&#x02019; to provide improved management regimes to ICU survivors.<xref rid="R7" ref-type="bibr">7</xref> The National Institute of Health and Care Excellence (NICE) clinical guidelines<xref rid="R8" ref-type="bibr">8</xref> provided by the National Health Service (NHS) NICE recommend &#x02018;optimisation of recovery&#x02019; rather than merely survival post-ICU. All of these problems are particularly present in survivors of sepsis.<xref rid="R9" ref-type="bibr">9</xref></p><p>Sepsis is defined as a powerful inflammatory response to severe infection.<xref rid="R10" ref-type="bibr">10</xref> The annual total cost of sepsis syndromes in the USA is $16.7 billion nationally<xref rid="R11" ref-type="bibr">11</xref> with the incidence projected to increase by 1.5% per annum as patients develop more comorbidities and resistant organisms. In brief, sepsis is a major public health concern.<xref rid="R12" ref-type="bibr">12</xref></p><p>However, the statistics above do not include the cost of ongoing disability and loss of productivity postillness. Patients with sepsis syndromes have significantly worse outcomes with lower health-related quality of life (HRQoL),<xref rid="R13" ref-type="bibr">13&#x02013;16</xref> particularly in the physical domain,<xref rid="R17" ref-type="bibr">17</xref>
<xref rid="R18" ref-type="bibr">18</xref> chronic pain<xref rid="R5" ref-type="bibr">5</xref>
<xref rid="R19" ref-type="bibr">19</xref> and cognitive domain<xref rid="R20" ref-type="bibr">20</xref> compared with non-septic ICU survivors. While other critically ill/injured or disabled patients, for example, those with burns, strokes, head injuries have established follow-up regimes, patients with sepsis are not referred to formal rehabilitation and are discharged home with extremely poor function.</p><p>Follow-up ICU outpatient clinics are a recent innovation particularly within the UK.<xref rid="R21" ref-type="bibr">21&#x02013;23</xref> These clinics identify and provide intervention for problems posthospital discharge including weakness, poor balance, impaired swallowing and nutrition, ongoing emotional problems and/or post-traumatic stress disorder in critical illness survivors. The one completed clinical trial on this topic<xref rid="R24" ref-type="bibr">24</xref> did not find a significant improvement in HRQoL. Researchers admitted that one discipline was not ideal and &#x02018;further work should focus on the roles of early physical rehabilitation, delirium, cognitive dysfunction and relatives&#x02019;. The programme was conducted in a generic group of ICU survivors including those with only an overnight stay, and there may be greater discriminatory power in selecting only one diagnostic group with a documented poor outcome such as sepsis syndrome. Additionally some countries (Canada, Australia, South Africa) have major problems with large land area and relatively sparse population in rural areas leading to a lack of resources and problems with follow-up post-ICU.<xref rid="R25" ref-type="bibr">25</xref></p></sec><sec id="s2"><title>Aims</title><p>The primary aim of this research is to investigate whether targeted follow-up and intervention will improve HRQoL in survivors of sepsis syndromes. Secondary aims will be to investigate whether this intervention decreases readmission rates to hospital, 12-month mortality and health resource use.</p><p>This project will be an important investigation of follow-up and management of ICU patients in a subpopulation (sepsis) documented to have poor outcomes.<xref rid="R16" ref-type="bibr">16</xref> The project will incorporate a subgroup (rural patients) via telemedicine<xref rid="R26" ref-type="bibr">26</xref> in a novel method to overcome the problem of the &#x02018;tyranny of distance&#x02019; in follow-up.</p><sec id="s2a"><title>Hypotheses</title><p>The hypotheses are that posthospital follow-up will improve HRQoL, decrease mortality, economic and health resource use and readmission to hospital in patients postadmission to ICU with sepsis syndrome.</p></sec></sec><sec id="s3"><title>Methods/design</title><p>This is a prospective, double-blinded, interventional, repeated measures, superiority, randomised controlled trial with concealed allocation, blinded assessors and intention-to-treat analysis. The study has been designed in accordance with the Consolidated Standards for Reporting of Trials guidelines<xref rid="R27" ref-type="bibr">27</xref> (<xref ref-type="fig" rid="BMJOPEN2014004966F1">figure 1</xref>) and the Standard Protocol items: Recommendation for Interventional Trials (SPIRIT 2013).<xref rid="R28" ref-type="bibr">28</xref> The trial will be completed in two outpatient clinics. One clinic will be in the outpatient department located at the university-affiliated tertiary hospital Royal Brisbane and Women&#x02019;s Hospital (RBWH), Brisbane, Australia; the other will be located at a regional hospital&#x02014;the Bundaberg Base Hospital, Bundaberg, Queensland, Australia.</p><fig id="BMJOPEN2014004966F1" position="float"><label>Figure&#x000a0;1</label><caption><p>CONSORT flow diagram.</p></caption><graphic xlink:href="bmjopen2014004966f01"/></fig><sec id="s3a"><title>Participants</title><p>Participants will be recruited from among patients being discharged from a quaternary university-affiliated ICU at RBWH, Brisbane, Australia. Participants will be randomised to one of the two groups (intervention or control) post-ICU discharge and just prior to discharge from hospital.</p><sec id="s3a1"><title>Inclusion criteria</title><p>Patients included will be men or women &#x02265;18&#x02005;years of age, with a documented episode(s) of sepsis<xref rid="R10" ref-type="bibr">10</xref> (&#x02265;2 criteria of a systemic inflammatory response plus proven or strongly suspected infection, severe sepsis defined as sepsis plus organ failure, septic shock defined as severe sepsis not responding to management) and required respiratory support for longer than 48&#x02005;h. Enrolment in the study should be within 1&#x02005;month of discharge from hospital.</p></sec><sec id="s3a2"><title>Exclusion criteria</title><p>Patients with neurological injuries, spinal injuries and burns will be excluded, as these patients have existing rehabilitation programmes and community support groups. Patients with haematological conditions or requiring palliative care post-ICU will also be excluded. Patients with psychiatric and/or mental disabilities that preclude them from understanding the questionnaires and non-English speaking patients will also be excluded.</p></sec></sec><sec id="s3b"><title>Randomisation</title><p>Participants will be randomised by opaque sealed envelopes after enrolment. Numbers on the envelopes will be generated by a computer-generated randomisation (<ext-link ext-link-type="uri" xlink:href="http://www.randomization.com">http://www.randomization.com</ext-link>) table based on blocks of four to assign patients to either the intervention or the usual care group. The randomisation sequence will be concealed from consent designee staff and protected by an electronic password. Participants will be stratified based on a score &#x0003e;3 on the Cumulative Illness Rating Scale (CIRS-G).<xref rid="R29" ref-type="bibr">29</xref></p><p>We are stratifying patients as most patients who develop sepsis syndromes have a number of comorbidities, but there can be a small number of relatively young, healthy patients who are affected. The allocation sequence will be generated by the research assistant attached to the trial. Patients will be consented by the chief investigator (JDP) and assigned to interventions by a second investigator (PT).</p></sec></sec><sec id="s4"><title>Intervention</title><sec id="s4a"><title>Intervention group</title><p>Patients in the intervention group will attend a follow-up clinic two monthly for up to 6&#x02005;months after discharge from the hospital. Screening instruments will be utilised on the first visit and appropriate management and referral provided. These will involve: overall medical review involving all systems assessment, medications, vital signs, physical activity assessment, muscle strength,<xref rid="R30" ref-type="bibr">30</xref> assessment of mobility (<italic>modified Rivermead Mobility Index</italic>),<xref rid="R31" ref-type="bibr">31</xref> balance assessment (<italic>Berg Balance measure</italic>),<xref rid="R32" ref-type="bibr">32</xref> discussion with carer as to concerns (<italic>Zarit Burden Interview</italic>),<xref rid="R33" ref-type="bibr">33</xref> screening for chronic pain syndromes (<italic>Brief Pain Inventory</italic>),<xref rid="R34" ref-type="bibr">34</xref> nutritional review, screening with the (<italic>PTSD</italic>) <italic>Checklist-Civilian Version</italic> (for post-traumatic stress syndrome),<xref rid="R35" ref-type="bibr">35</xref>
<italic>generalised anxiety disorder (GAD-7</italic>)<xref rid="R36" ref-type="bibr">36</xref> and <italic>The Patient Health Questionnaire-9 for depression.</italic><xref rid="R37" ref-type="bibr">37</xref> Following the results of the screening and team discussion, participants and/or carer will be referred to appropriate agencies including the general practitioner, specialist, physiotherapist, nutritionist, speech pathologist, exercise physiologist, psychologist and/or occupational therapist. These instruments are screens for post-ICU problems that have been identified in previous studies.<xref rid="R13" ref-type="bibr">13&#x02013;20</xref> Members of the research team include an intensivist/thoracic physician, two specialist respiratory physiotherapists, a psychologist, a senior nurse researcher, a professor of community and general practice and a health economist/community physiotherapist. This individualised management is in line with recommendations of the NICE clinical guidelines.<xref rid="R8" ref-type="bibr">8</xref></p></sec><sec id="s4b"><title>Standard care</title><p>Patients in the control group will have usual care, that is, they will be referred to specialist outpatient clinics and/or general practitioners on discharge.</p></sec><sec id="s4c"><title>Subgroup&#x02014;rural patients</title><p>A small number of patients (10) originally managed in the major quaternary level ICU will be discharged to a rural area. We will test the feasibility of providing follow-up care to these patients. These patients will also be randomised to either the intervention or the usual care group. The patients will be interviewed via telemedicine (videoconferencing)<xref rid="R26" ref-type="bibr">26</xref> and a research assistant will be appointed to complete other screening tools and refer them to appropriate agencies. If specialist services are required, for example, chronic pain clinic, these may also be accessed via telemedicine.</p></sec></sec><sec id="s5"><title>Outcome measures</title><sec id="s5a"><title>Primary measure</title><p>The primary measure will be HRQoL as measured by the Short Form 36 health survey V.2 (SF36V.2)<xref rid="R38" ref-type="bibr">38</xref> which demonstrates content and construct validity, sensitivity and responsiveness to change in many patient groups<xref rid="R39" ref-type="bibr">39</xref> including ICU and postsepsis survivors.<xref rid="R40" ref-type="bibr">40</xref> Pilot testing of the SF36 in this population by this team has been conducted in a current trial of inpatients postsepsis and has shown excellent completion rates at 6&#x02005;months by telephone.<xref rid="R41" ref-type="bibr">41</xref></p></sec><sec id="s5b"><title>Secondary measures</title><p>Patients&#x02019; readmission rates to hospital (medical record data), 12-month mortality (only expectedtrend) and economics and healthcare resource use. The latter will be monitored through examination of patient medical records, patient self-report and through Medicare/Pharmaceutical Benefits Scheme data extraction. The SF6D<xref rid="R42" ref-type="bibr">42</xref> is a preference based six-dimensional health state measure suitable for economic evaluation that is derived from the SF36. The SF6D defines 249 health states, and a summary utility score for the SF6D will be calculated using UK weights.</p><p>Individual patient productivity will be measured using a work/activity impairment questionnaire, the Work Productivity and Activity Impairment Questionnaire (WPAI).<xref rid="R43" ref-type="bibr">43</xref></p><p>The outcome measure of SF36V.2 will be taken at baseline, 6 and 12&#x02005;months postenrolment in the study. All other measures (mortality, hospital readmission and economic and health resource use) will be taken at 6 and 12&#x02005;months postenrolment.</p></sec><sec id="s5c"><title>Sample size</title><p>Power calculations are based on SF36 using previously published Minimally Clinically Important Differences (MCIDs) for the SF36 physical domain scores of 7.8 points (SD 15) in our pilot trial on rehabilitation in sepsis.<xref rid="R41" ref-type="bibr">41</xref> The sample size, based on a two sample comparison of means was calculated at 78/group for the SF36 at 90% power with a two-sided, &#x003b1; error level of 0.05. Allowing for an almost 30% loss to follow-up (mortality, dropouts), a total of 204 participants will be required.<xref rid="R44" ref-type="bibr">44</xref></p></sec><sec id="s5d"><title>Planned statistical analysis</title><sec id="s5d1"><title>Primary outcomes</title><p>A baseline comparison of demographics, length of stay in ICU, severity of illness, Acute Physiological and Chronic Health Evaluation score (APACHE II) on admission to ICU<xref rid="R45" ref-type="bibr">45</xref> and baseline measures will be carried out between each group, using a combination of t tests and &#x003c7;<sup>2</sup> test.</p><p>Generalised estimating equations (GEE) will be used to compare the SF36 domain scores between groups and across time points. The GEE is a flexible technique that takes into account the correlations among individuals in longitudinal study designs and can account for missing data without a need for imputation techniques.<xref rid="R46" ref-type="bibr">46</xref></p></sec><sec id="s5d2"><title>Secondary outcomes</title><p>Mortality will be compared between groups using a Cox proportional hazards (time until death) analysis.<xref rid="R47" ref-type="bibr">47</xref> Time to first readmission will be compared between groups by a survival analysis. Utility estimates derived from the SF6D will be analysed using a GEE. Healthcare costs will be compared between groups using a generalised linear model to account for the non-normal distribution. Economic (health resource) evaluation will be a within-trial incremental cost utility analysis with a societal perspective.<xref rid="R48" ref-type="bibr">48</xref> Direct costs included will be: cost of care provided in hospitals, by general practitioners, home nursing, complementary (allied) health providers, alternative health providers, opportunity cost of unpaid carers, cost of transportation to programme and to other health services and cost of pharmaceuticals. Indirect costs include loss of productivity due to disease, such as time lost from work or providing informal care to another individual. All costs will be valued using market costs where available and productivity costs will be valued using actual patient wage rates.</p><p>The subgroup of rural patients will be analysed in the full analysis and subgroup results will be compared with metropolitan patients.</p></sec><sec id="s5d3"><title>Data management</title><p>A custom-designed database will store de-identified patient data on a secure password protected file. This will be entered from hard copies of the scoring sheets. Data will be reviewed by research office staff twice yearly and cross referenced with stored hard copies. A data management committee comprising a senior ICU specialist, a senior critical care nurse and a senior physiotherapist will review the data every 6&#x02005;months.</p></sec><sec id="s5d4"><title>Contingencies</title><p>If participant recruitment does not reach the required sample size in 2&#x02005;years, the study can be extended for a further 1&#x02013;2&#x02005;years.</p></sec></sec><sec id="s5e"><title>Methods for protecting against other sources of bias</title><p>This study will be double blinded with the assessors, data analysts and a number of investigators (TC, FC and GM) blinded from group allocation. There will be concealed allocation of participants. Participants will be stratified for CIRS-G.<xref rid="R29" ref-type="bibr">29</xref> Participants when being consented will be told that they will be in one of the two groups which will be followed up posthospital and they may need to attend an outpatient clinic. Patients are unaware of the usual follow-up posthospital so should not feel they are receiving an increased/decreased level of care. Both groups will be contacted by telephone for completion of HRQoL life instruments at the required stages. Participants may have varying severity of illness, lengths of stay and/or time on mechanical ventilation in ICU; however, this will be compared between groups and if unequal adjusted models using the relevant covariates will be presented as well as unadjusted comparisons.</p><p>A few participants in either group may be referred to rehabilitation by their treating physician. This will be compared between groups. A number of patients may be uncontactable for final outcome measures; however, we have had a 95% rate in the current trial at 6&#x02005;months postsepsis.<xref rid="R41" ref-type="bibr">41</xref> The GEE<xref rid="R46" ref-type="bibr">46</xref> will allow for missing data. If patients &#x02018;cross-over&#x02019;, that is, do not receive the planned intervention, they will still be analysed with the group they originally enrolled as per intention to treat.</p></sec></sec><sec id="s6"><title>Ethics and dissemination</title><p>The trial has been registered on the Australian and New Zealand Clinical Trials Registry (ACTRN12613000528752).</p><p>Any adverse events connected to the trial will be immediately reported to one of the following three committees: RBWH Human Research Ethics Committee, The University of Queensland, Griffith University and the Australian Government Department of Health.</p><p>The results of this study will be submitted for publication to peer-reviewed ICU journals and presented at national and international ICU and/or rehabilitation conferences.</p></sec><sec sec-type="conclusions" id="s7"><title>Conclusion</title><p>Follow-up post-ICU stay is presently a topic of great interest with a realisation that surviving critical illness may result in poor quality of life. Patients who have had severe sepsis syndromes have been shown to have a poorer quality of life and outcome than generic ICU patients. This study will investigate whether targeted intervention from a multidisciplinary team will result in benefits and is economically feasible for this group of patients.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="d35e299" content-type="local-data"><caption><title>Author's manuscript</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="bmjopen-2014-004966.draft_revisions.pdf"/></supplementary-material><supplementary-material id="d35e300" content-type="local-data"><caption><title>Reviewer comments</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="bmjopen-2014-004966.reviewer_comments.pdf"/></supplementary-material></sec></body><back><fn-group><fn><p><bold>Contributors:</bold> All authors participated in the manuscript preparation, writing and editing. SS participated in grant writing and protocol development.</p></fn><fn><p><bold>Funding:</bold> Funding has been provided for this study from the Royal Brisbane and Womens&#x02019; Hospital Research Foundation ($40&#x02005;000) and the Physiotherapy Research Fellowship, Health and Medical Research, Queensland Government ($182&#x02005;000).</p></fn><fn><p><bold>Competing interests:</bold> None.</p></fn><fn><p><bold>Ethics approval:</bold> Royal Brisbane and Women's Hospital Human Research Ethics Committee (HREC; HREC/13/QRBW/17), The University of Queensland HREC (2013000543), Griffith University (RHS/08/14/HREC) and the Australian Government Department of Health (26/2013).</p></fn><fn><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oeyen</surname><given-names>SG</given-names></name><name><surname>Vandijck</surname><given-names>DM</given-names></name><name><surname>Benoit</surname><given-names>DB</given-names></name><etal/></person-group>
<article-title>Quality of life after intensive care: a systematic review of the literature</article-title>. <source>Crit Care Med</source>
<year>2010</year>;<volume>38</volume>:<fpage>2386</fpage>&#x02013;<lpage>400</lpage><pub-id pub-id-type="pmid">20838335</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myhren</surname><given-names>H</given-names></name><name><surname>Ekeberg</surname><given-names>O</given-names></name><name><surname>Stokland</surname><given-names>O</given-names></name></person-group>
<article-title>Health related quality of life and return to work after critical illness in general intensive care unit patients: a 1-year follow up study</article-title>. <source>Crit Care Med</source>
<year>2010</year>;<volume>38</volume>:<fpage>1554</fpage>&#x02013;<lpage>61</lpage><pub-id pub-id-type="pmid">20473149</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>TA</given-names></name><name><surname>Dobb</surname><given-names>GJ</given-names></name><name><surname>Finn</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>Long term survival from intensive care: a review</article-title>. <source>Intensive Care Med</source>
<year>2005</year>;<volume>31</volume>:<fpage>1306</fpage>&#x02013;<lpage>15</lpage><pub-id pub-id-type="pmid">16132895</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname><given-names>SV</given-names></name><name><surname>Law</surname><given-names>TJ</given-names></name><name><surname>Needham</surname><given-names>DM</given-names></name></person-group>
<article-title>Long-term complications of critical care</article-title>. <source>Crit Care Med</source>
<year>2011</year>;<volume>39</volume>:<fpage>371</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="pmid">20959786</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battle</surname><given-names>CE</given-names></name><name><surname>Lovett</surname><given-names>S</given-names></name><name><surname>Hutchings</surname><given-names>H</given-names></name></person-group>
<article-title>Chronic pain in survivors of critical illness: a retrospective analysis of incidence and risk factors</article-title>. <source>Crit Care</source>
<year>2013</year>;<volume>17</volume>:<fpage>R101</fpage>
<comment><ext-link ext-link-type="uri" xlink:href="http://ccforum.com.contnet/17/3/R101">http://ccforum.com.contnet/17/3/R101</ext-link></comment><pub-id pub-id-type="pmid">23718685</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>J</given-names></name><name><surname>Hatch</surname><given-names>RA</given-names></name><name><surname>Bishop</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>An exploration of social and economic outcome and health related quality of life after critical illness in general intensive care unit survivors: a 12-month follow-up study</article-title>. <source>Crit Care</source>
<year>2013</year>;<volume>17</volume>:<fpage>R100</fpage>
<comment><ext-link ext-link-type="uri" xlink:href="http://ccforum.com/content/17/3/R100">http://ccforum.com/content/17/3/R100</ext-link></comment><pub-id pub-id-type="pmid">23714692</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Needham</surname><given-names>DM</given-names></name><name><surname>Feldman</surname><given-names>DR</given-names></name><name><surname>Kho</surname><given-names>ME</given-names></name></person-group>
<article-title>The functional costs of ICU survivorship. Collaborating to improve post-ICU disability</article-title>. <source>Am J Respir Crit Care Med</source>
<year>2011</year>;<volume>183</volume>:<fpage>1037</fpage>&#x02013;<lpage>42</lpage><pub-id pub-id-type="pmid">21057004</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="other"><collab>Rehabilitation after critical illness</collab>. <comment>NHS National Institute for Health and Clinical Excellence</comment>
<year>2009</year>
<comment><ext-link ext-link-type="uri" xlink:href="http://www.guidance.nice.org.uk/cg83">http://www.guidance.nice.org.uk/cg83</ext-link></comment></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofhuis</surname><given-names>JGM</given-names></name><name><surname>Spronk</surname><given-names>PE</given-names></name><name><surname>van Stel</surname><given-names>HF</given-names></name><etal/></person-group>
<article-title>The impact of severe sepsis on health related quality of life: a long term follow up study</article-title>. <source>Crit Care Trauma</source>
<year>2008</year>;<volume>107</volume>:<fpage>1957</fpage>&#x02013;<lpage>64</lpage></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Fink</surname><given-names>MP</given-names></name><name><surname>Marshall</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference</article-title>. <source>Intensive Care Med</source>
<year>2003</year>;<volume>29</volume>:<fpage>530</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="pmid">12664219</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angus</surname><given-names>DC</given-names></name><name><surname>Lind-Zwirble</surname><given-names>WT</given-names></name><name><surname>Lidicker</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Epidemiology of severe sepsis in the United States analysis of incidence outcome, and associated costs</article-title>. <source>Crit Care Med</source>
<year>2001</year>;<volume>29</volume>:<fpage>1303</fpage>&#x02013;<lpage>10</lpage><pub-id pub-id-type="pmid">11445675</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>E</given-names></name><name><surname>Araujo</surname><given-names>DV</given-names></name></person-group>
<article-title>Economic and social burden of sepsis. In: Yearbook of Intensive Care and Emergency Medicine</article-title>. <comment>Vincent J-L, Eds. Berlin: Springer-Verlag</comment>, <year>2009</year>:<fpage>129</fpage>&#x02013;<lpage>38</lpage></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>S</given-names></name><name><surname>Ruokonen</surname><given-names>E</given-names></name><name><surname>Varpula</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Long-term outcome and quality adjusted life years after severe sepsis</article-title>. <source>Crit Care Med</source>
<year>2009</year>;<volume>37</volume>:<fpage>1268</fpage>&#x02013;<lpage>74</lpage><pub-id pub-id-type="pmid">19242321</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Fang</surname><given-names>Q</given-names></name><etal/></person-group>
<article-title>Impaired long-term quality of life in survivors of severe sepsis Chinese multicenter study over 6 years</article-title>. <source>Anaesthesist</source>
<year>2013</year>;<volume>62</volume>:<fpage>995</fpage>&#x02013;<lpage>1002</lpage><pub-id pub-id-type="pmid">24292122</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuthbertson</surname><given-names>BH</given-names></name><name><surname>Elder</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Mortality and quality of life in the five years after severe sepsis</article-title>. <source>Crit Care</source>
<year>2013</year>;<volume>17</volume>:<fpage>R70</fpage>
<comment><ext-link ext-link-type="uri" xlink:href="http://ccforum.com/content/17/2/R70">http://ccforum.com/content/17/2/R70</ext-link></comment><pub-id pub-id-type="pmid">23587132</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winters</surname><given-names>BD</given-names></name><name><surname>Eberlein</surname><given-names>M</given-names></name><name><surname>Leung</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Long-term mortality and quality of life in sepsis: a systematic review</article-title>. <source>Crit Care Med</source>
<year>2010</year>;<volume>38</volume>:<fpage>1276</fpage>&#x02013;<lpage>83</lpage><pub-id pub-id-type="pmid">20308885</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paratz</surname><given-names>JD</given-names></name><name><surname>Kayambu</surname><given-names>G</given-names></name></person-group>
<article-title>Early exercise and attenuation of myopathy in the patient with sepsis in ICU</article-title>. <source>Phys Ther Rev</source>
<year>2011</year>;<volume>16</volume>:<fpage>58</fpage>&#x02013;<lpage>65</lpage></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>CE</given-names></name><name><surname>Bersten</surname><given-names>AD</given-names></name></person-group>
<article-title>Alterations in respiratory and limb muscle strength and size in patients with sepsis who are mechanically ventilated</article-title>. <source>Phys Ther</source>
<year>2014</year>;<volume>94</volume>:<fpage>68</fpage>&#x02013;<lpage>82</lpage><pub-id pub-id-type="pmid">24009347</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmer</surname><given-names>A</given-names></name><name><surname>Rothaug</surname><given-names>J</given-names></name><name><surname>Mescha</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Chronic pain after surviving sepsis</article-title>. <source>Crit Care</source>
<year>2006</year>;<volume>10</volume><issue>(Suppl 1)</issue>:<fpage>421</fpage><pub-id pub-id-type="pmid">16959049</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwashyna</surname><given-names>TJ</given-names></name><name><surname>Ely</surname><given-names>EW</given-names></name><name><surname>Smith</surname><given-names>DM</given-names></name><etal/></person-group>
<article-title>Long-term cognitive impairment and functional disability among survivors of severe sepsis</article-title>. <source>JAMA</source>
<year>2010</year>;<volume>304</volume>:<fpage>1787</fpage>&#x02013;<lpage>94</lpage><pub-id pub-id-type="pmid">20978258</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>JA</given-names></name><name><surname>Barber</surname><given-names>VS</given-names></name><name><surname>Cuthbertson</surname><given-names>BH</given-names></name><etal/></person-group>
<article-title>A national survey of intensive care follow-up clinics</article-title>. <source>Anaesthesia</source>
<year>2006</year>;<volume>61</volume>:<fpage>950</fpage>&#x02013;<lpage>5</lpage><pub-id pub-id-type="pmid">16978309</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bambi</surname><given-names>S</given-names></name><name><surname>Solaro</surname><given-names>M</given-names></name><name><surname>Cianchi</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Outpatient intensive care unit follow-up services in Italy: a national survey: a brief report</article-title>. <source>Dimens Crit Care Nurs</source>
<year>2013</year>;<volume>32</volume>:<fpage>46</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="pmid">23222231</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>TA</given-names></name><name><surname>Leslie</surname><given-names>GD</given-names></name></person-group>
<article-title>Beyond the walls: a review of ICU clinics and their impact on patient outcomes after leaving hospital</article-title>. <source>Aust Crit Care</source>
<year>2008</year>;<volume>21</volume>:<fpage>6</fpage>&#x02013;<lpage>17</lpage><pub-id pub-id-type="pmid">18206381</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuthbertson</surname><given-names>BH</given-names></name><name><surname>Rattray</surname><given-names>J</given-names></name><name><surname>Campbell</surname><given-names>MK</given-names></name><etal/></person-group>
<article-title>The PRaCTICal study of nurse led, intensive care follow up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial</article-title>. <source>BMJ</source>
<year>2009</year>;<volume>339</volume>:<fpage>b3723</fpage><pub-id pub-id-type="pmid">19837741</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>TA</given-names></name><name><surname>Leslie</surname><given-names>GD</given-names></name></person-group>
<article-title>Challenges and possible solutions for long-term follow-up of patients surviving critical illness</article-title>. <source>Aust Crit Care</source>
<year>2011</year>;<volume>24</volume>:<fpage>175</fpage>&#x02013;<lpage>85</lpage><pub-id pub-id-type="pmid">21514838</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boots</surname><given-names>RJ</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Terblanche</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Remote care by telemedicine in the ICU: many models of care can be effective</article-title>. <source>Curr Opin Crit Care</source>
<year>2011</year>;<volume>17</volume>:<fpage>634</fpage>&#x02013;<lpage>40</lpage><pub-id pub-id-type="pmid">22067879</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Schulz</surname><given-names>K</given-names></name><name><surname>Altman</surname><given-names>D</given-names></name></person-group>
<article-title>The CONSORT statement: revised recommendations for improving the quality of parallel&#x02013;group randomized controlled trials</article-title>. <source>Ann Internal Med</source>
<year>2001</year>;<volume>134</volume>:<fpage>657</fpage>&#x02013;<lpage>62</lpage><pub-id pub-id-type="pmid">11304106</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>AW</given-names></name><name><surname>Teztlaff</surname><given-names>JM</given-names></name><name><surname>Gotzsche</surname><given-names>PC</given-names></name><etal/></person-group>
<article-title>SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials</article-title>. <source>BMJ</source>
<year>2013</year>;<volume>346</volume>:<fpage>37586</fpage></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldman</surname><given-names>E</given-names></name><name><surname>Potter</surname><given-names>JF</given-names></name></person-group>
<article-title>A prospective evaluation of the Cumulative Illness Rating Scale</article-title>. <source>Aging</source>
<year>1992</year>;<volume>4</volume>:<fpage>171</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="pmid">1387004</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>CE</given-names></name><name><surname>Paratz</surname><given-names>JD</given-names></name><name><surname>Bersten</surname><given-names>AD</given-names></name></person-group>
<article-title>Muscle strength assessment in critically ill patients with handheld dynamometry: an investigation of reliability, minimal detectable change, and time to peak force generation</article-title>. <source>J Crit Care</source>
<year>2012</year>;<volume>28</volume>:<fpage>77</fpage>&#x02013;<lpage>86</lpage><pub-id pub-id-type="pmid">22520490</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lennon</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>L</given-names></name></person-group>
<article-title>The modified Rivermead Mobility Index: validity and reliability</article-title>. <source>Disabil Rehabil</source>
<year>2000</year>;<volume>22</volume>:<fpage>833</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="pmid">11197520</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorbahn</surname><given-names>LD</given-names></name><name><surname>Newton</surname><given-names>RA</given-names></name></person-group>
<article-title>Use of the Berg Balance test to predict falls in elderly persons</article-title>. <source>Phys Ther</source>
<year>1996</year>;<volume>76</volume>:<fpage>576</fpage>&#x02013;<lpage>85</lpage><pub-id pub-id-type="pmid">8650273</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarit</surname><given-names>SH</given-names></name><name><surname>Reever</surname><given-names>KE</given-names></name><name><surname>Bach-Peterson</surname><given-names>J</given-names></name></person-group>
<article-title>Relatives of the impaired elderly: correlates of feelings of burden</article-title>. <source>Gerontologist</source>
<year>1980</year>;<volume>20</volume>:<fpage>649</fpage>&#x02013;<lpage>55</lpage><pub-id pub-id-type="pmid">7203086</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cleeland</surname><given-names>CS</given-names></name></person-group>
<article-title>Measurement of pain by subjective report</article-title>. In: <person-group person-group-type="editor"><name><surname>Chapman</surname><given-names>CR</given-names></name><name><surname>Loeser</surname><given-names>JD</given-names></name></person-group>, eds. <source>Advances in pain research and therapy, volume 12: issues in pain measurement</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Raven Press</publisher-name>, <year>1989</year>:<fpage>391</fpage>&#x02013;<lpage>403</lpage></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conybeare</surname><given-names>D</given-names></name><name><surname>Behar</surname><given-names>E</given-names></name><name><surname>Solomon</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The PTSD Checklist-Civilian Version: reliability, validity, and factor structure in a nonclinical sample</article-title>. <source>J Clin Psychol</source>
<year>2012</year>;<volume>68</volume>:<fpage>699</fpage>&#x02013;<lpage>713</lpage><pub-id pub-id-type="pmid">22517497</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>JBW</given-names></name><etal/></person-group>
<article-title>A brief measure for assessing generalized anxiety disorder</article-title>. <source>Arch Intern Med</source>
<year>2006</year>;<volume>166</volume>:<fpage>1092</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="pmid">16717171</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JBW</given-names></name></person-group>
<article-title>The PHQ-9 validity of a brief depression severity measure</article-title>. <source>J Gen Intern Med</source>
<year>2001</year>;<volume>16</volume>:<fpage>606</fpage>&#x02013;<lpage>13</lpage><pub-id pub-id-type="pmid">11556941</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>JD</given-names></name><name><surname>Sherbourne</surname><given-names>CD</given-names></name></person-group>
<article-title>The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection</article-title>. <source>Med Care</source>
<year>1992</year>;<volume>30</volume>:<fpage>473</fpage>&#x02013;<lpage>83</lpage><pub-id pub-id-type="pmid">1593914</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contopoulos-Ioannidis</surname><given-names>DG</given-names></name><name><surname>Karvouni</surname><given-names>A</given-names></name><name><surname>Kouri</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review</article-title>. <source>BMJ</source>
<year>2009</year>;<volume>338</volume>:<fpage>a3006</fpage><pub-id pub-id-type="pmid">19139138</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heyland</surname><given-names>DK</given-names></name><name><surname>Hopman</surname><given-names>W</given-names></name><name><surname>Coo</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Long-term health-related quality of life in survivors of sepsis. Short Form 36: a valid and reliable measure of health-related quality of life</article-title>. <source>Crit Care Med</source>
<year>2000</year>;<volume>28</volume>:<fpage>3599</fpage>&#x02013;<lpage>605</lpage><pub-id pub-id-type="pmid">11098960</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayambu</surname><given-names>G</given-names></name><name><surname>Boots</surname><given-names>R</given-names></name><name><surname>Paratz</surname><given-names>J</given-names></name></person-group>
<article-title>A prospective randomised controlled trial investigating functional and physiological outcomes following early rehabilitation in sepsis: the i-PERFORM Trial&#x02014;protocol article</article-title>. <source>BMC Anesthesiol</source>
<year>2011</year>;<volume>11</volume>:<fpage>21</fpage><pub-id pub-id-type="pmid">22035174</pub-id></mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brazier</surname><given-names>J</given-names></name><name><surname>Roberts</surname><given-names>J</given-names></name><name><surname>Deverill</surname><given-names>M</given-names></name></person-group>
<article-title>The estimation of a preference-based measure of health from the SF-36</article-title>. <source>J Health Econ</source>
<year>2002</year>;<volume>21</volume>:<fpage>271</fpage>&#x02013;<lpage>92</lpage><pub-id pub-id-type="pmid">11939242</pub-id></mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reilly</surname><given-names>MC</given-names></name><name><surname>Zbrozek</surname><given-names>AS</given-names></name><name><surname>Dukes</surname><given-names>E</given-names></name></person-group>
<article-title>The validity and reproducibility of a work productivity and activity impairment measure</article-title>. <source>Pharmacoeconomics</source>
<year>1993</year>;<volume>4</volume>:<fpage>353</fpage>&#x02013;<lpage>65</lpage><pub-id pub-id-type="pmid">10146874</pub-id></mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J</given-names></name></person-group>
<source>Statistical power analysis for the behavioral sciences</source>. <publisher-loc>Hillsdale, NJ</publisher-loc>: <publisher-name>Erlbaum</publisher-name>, <year>1988</year></mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knaus</surname><given-names>WA</given-names></name><name><surname>Draper</surname><given-names>EA</given-names></name><name><surname>Wagner</surname><given-names>DP</given-names></name><etal/></person-group>
<article-title>APACHE II: a severity of disease classification system</article-title>. <source>Crit Care Med</source>
<year>1985</year>;<volume>13</volume>:<fpage>818</fpage>&#x02013;<lpage>29</lpage><pub-id pub-id-type="pmid">3928249</pub-id></mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Twisk</surname><given-names>J</given-names></name><name><surname>de Vente</surname><given-names>W</given-names></name></person-group>
<article-title>Attrition in longitudinal studies. How to deal with missing data</article-title>. <source>J Clin Epidemiol</source>
<year>2002</year>;<volume>55</volume>:<fpage>329</fpage>&#x02013;<lpage>37</lpage><pub-id pub-id-type="pmid">11927199</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenfeld</surname><given-names>D</given-names></name></person-group>
<article-title>Sample-size formula for the proportional-hazards regression model</article-title>. <source>Biometrics</source>
<year>1983</year>;<volume>39</volume>:<fpage>499</fpage>&#x02013;<lpage>503</lpage><pub-id pub-id-type="pmid">6354290</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>M</given-names></name><name><surname>O'Brien</surname><given-names>B</given-names></name><name><surname>Stoddart</surname><given-names>G</given-names></name><etal/></person-group>
<source>Methods for the economic evaluation of health care programmes</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Oxford Medical Publications</publisher-name>, <year>1993</year></mixed-citation></ref></ref-list></back></article>